Creative Planning Alaunos Therapeutics, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $34 - $111	860 Added 3.48%	25,597 $1,000
Q2 2023 Jul 21, 2023	BUY	$0.43 - $0.65 $1 - $2	4 Added 0.02%	24,737 $12,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $1,129 - $1,989	2,456 Added 11.02%	24,733 $15,000
Q4 2022 Feb 10, 2023	SELL	$0.5 - $261.0 $1,980 - $1.03 Million	-3,960 Reduced 15.09%	22,277 $14,000
Q3 2022 Nov 03, 2022	BUY	$1.04 - $322.5 $52 - $16,125	50 Added 0.19%	26,237 $45,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $122 - $372	300 Added 1.16%	26,187 $32,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $912 - $1,721	-1,471 Reduced 5.38%	25,887 $17,000
Q4 2021 Feb 11, 2022	SELL	$1.09 - $1.89 $340 - $589	-312 Reduced 1.13%	27,358 $30,000
Q3 2021 Nov 10, 2021	BUY	$1.44 - $2.73 $2,609 - $4,946	1,812 Added 7.01%	27,670 $50,000
Q2 2021 Aug 04, 2021	SELL	$2.63 - $3.67 $5,365 - $7,486	-2,040 Reduced 7.31%	25,858 $68,000
Q1 2021 Apr 30, 2021	SELL	$2.82 - $5.6 $3,220 - $6,395	-1,142 Reduced 3.93%	27,898 $100,000
Q4 2020 Jan 29, 2021	SELL	$2.09 - $3.09 $2,090 - $3,090	-1,000 Reduced 3.33%	29,040 $73,000
Q2 2020 Jul 23, 2020	SELL	$2.2 - $3.71 $12,117 - $20,434	-5,508 Reduced 15.49%	30,040 $99,000
Q1 2020 May 05, 2020	BUY	$1.9 - $4.98 $4,750 - $12,450	2,500 Added 7.56%	35,548 $87,000
Q4 2019 Jan 30, 2020	SELL	$3.95 - $5.35 $198,574 - $268,955	-50,272 Reduced 60.34%	33,048 $156,000
Q3 2019 Nov 01, 2019	SELL	$4.13 - $6.94 $28,084 - $47,192	-6,800 Reduced 7.55%	83,320 $357,000
Q2 2019 Jul 26, 2019	BUY	$3.98 - $6.2 $59,700 - $93,000	15,000 Added 19.97%	90,120 $525,000
Q1 2019 Apr 24, 2019	BUY	$2.0 - $4.4 $29,848 - $65,665	14,924 Added 24.79%	75,120 $289,000
Q4 2018 Feb 01, 2019	SELL	$1.61 - $3.62 $16,752 - $37,666	-10,405 Reduced 14.74%	60,196 $113,000
Q3 2018 Oct 25, 2018	SELL	$2.26 - $3.27 $45 - $65	-20 Reduced 0.03%	70,601 $226,000
Q2 2018 Jul 20, 2018	BUY	$3.02 - $4.94 $3,020 - $4,940	1,000 Added 1.44%	70,621 $213,000
Q1 2018 Apr 18, 2018	SELL	$3.46 - $5.14 $719 - $1,069	-208 Reduced 0.3%	69,621 $273,000
Q4 2017 Jan 17, 2018	BUY	$4.0 - $6.54 $40,632 - $66,433	10,158 Added 17.02%	69,829 $289,000
Q3 2017 Oct 17, 2017	BUY	$4.99 - $6.57 $297,758 - $392,038	59,671	59,671 $366,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $398M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account